A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring

• मुख्य लेखकों: Christeen Samuel (लेखक), Hannah Cornman (लेखक), Anusha Kambala (लेखक), Shawn G. Kwatra (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Adis, Springer Healthcare, 2023-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions. The US Food and Drug Administration (FDA) recently placed a black box warning on this class of medications due to safety concerns based on data from studies...